Effect of Diabetes Mellitus on Pharmacokinetic and Pharmacodynamic Properties of Drugs

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Clinical Pharmacokinetics

• Publication date

  2012-12-13

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/BF03261926PMID 22668340
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Reduced levels of active GLP-1 in patients with cystic fibrosis with and without diabetes mellitus.

  2012cited by this paper
• The Concentration of Cyclosporine Metabolites Is Significantly Lower in Kidney Transplant Recipients With Diabetes Mellitus

  2012cited by this paper
• Repaglinide

  2012cited by this paper
• Risk factors for development of new‐onset diabetes mellitus after transplant in adult lung transplant recipients

  2011cited by this paper
• Need for better diabetes treatment for improved renal outcome.

  2011cited by this paper
• Gastric emptying, incretin hormone secretion, and postprandial glycemia in cystic fibrosis--effects of pancreatic enzyme supplementation.

  2011cited by this paper
• Biomarkers for the Prediction of Type 2 Diabetes and Cardiovascular Disease

  2011cited by this paper
• What's fueling the biotech engine--2010 to 2011.

  2011cited by this paper
• Delayed gastric emptying is related to cardiovascular autonomic neuropathy in Chinese patients with type 2 diabetes.

  2011cited by this paper
• Significantly reduced cytochrome P450 3A4 expression and activity in liver from humans with diabetes mellitus

  2011cited by this paper
• Diabetic gastroparesis—Backwards and forwards

  2011cited by this paper
• New physiological effects of the incretin hormones GLP-1 and GIP.

  2011cited by this paper
• Effect of Obesity on the Pharmacokinetics of Drugs in Humans

  2010cited by this paper
• Pharmacokinetics of drugs in rats with diabetes mellitus induced by alloxan or streptozocin: comparison with those in patients with type I diabetes mellitus

  2010cited by this paper
• Diabetes mellitus and gastric emptying: questions and issues in clinical practice

  2009cited by this paper
• Blood flow in subcutaneous fat tissue in patients with diabetes mellitus.

  2009cited by this paper
• The biological properties of human insulin. Subcutaneous absorption, receptor binding and the clinical effect in diabetics assessed by a new statistical method.

  2009cited by this paper
• Effects of cisapride on gastroparesis in patients with insulin-dependent diabetes mellitus. A double-blind controlled trial.

  2009cited by this paper
• Effect of glycaemic control on glomerular filtration rate in diabetes mellitus patients.

  2009cited by this paper
• Differences in intragastric pH in diabetic vs. idiopathic gastroparesis: relation to degree of gastric retention.

  2008cited by this paper
• Economic Costs of Diabetes in the U.S. in 2007

  2008cited by this paper
• Blood and Plasma Pharmacokinetics of Ciclosporin in Diabetic Kidney Transplant Recipients

  2008cited by this paper
• Reduced Expression of ATP-Binding Cassette Transporter G1 Increases Cholesterol Accumulation in Macrophages of Patients With Type 2 Diabetes Mellitus

  2008cited by this paper
• Statin induced myotoxicity: the lactone forms are more potent than the acid forms in human skeletal muscle cells in vitro.

  2008cited by this paper
• Determinants of leukocyte adenosine triphosphate-binding cassette transporter G1 gene expression in type 2 diabetes mellitus.

  2008cited by this paper
• Cardiac remodeling in obesity.

  2008cited by this paper
• Pharmacokinetics of lidocaine and its metabolite in peridural anesthesia administered to pregnant women with gestational diabetes mellitus

  2008cited by this paper
• Video-capsule endoscopy gastric and small bowel transit time and completeness of the examination in patients with diabetes mellitus.

  2007cited by this paper
• Tacrolimus in Diabetic Kidney Transplant Recipients: Pharmacokinetics and Application of a Limited Sampling Strategy

  2007cited by this paper
• Effects of gastric emptying on oral mycophenolic acid pharmacokinetics in stable renal allograft recipients.

  2007cited by this paper
• Effect of Diabetes Mellitus on Mycophenolate Sodium Pharmacokinetics and Inosine Monophosphate Dehydrogenase Activity in Stable Kidney Transplant Recipients

  2007cited by this paper
• Neutrophil function and metabolism in individuals with diabetes mellitus.

  2007cited by this paper
• Mechanisms and Outcomes of Drug- and Toxicant-Induced Liver Toxicity in Diabetes

  2007cited by this paper
• Diabetic Gastroparesis

  2007cited by this paper
• Risk Factors for Hospitalization for Bacterial or Viral Infection in Renal Transplant Recipients—An Analysis of USRDS Data

  2007cited by this paper
• Therapeutic drug monitoring of mycophenolic acid.

  2007cited by this paper
• Nonalcoholic Fatty liver disease and obesity.

  2007cited by this paper
• The Relationship Between Diabetes and Infectious Hospitalizations in Renal Transplant Recipients

  2007cited by this paper
• The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes.

  2006cited by this paper
• Cardiovascular risk factors and disease management in type 2 diabetic patients with diabetic nephropathy.

  2006cited by this paper
• Amadori-modified glycated serum proteins and accelerated atherosclerosis in diabetes: pathogenic and therapeutic implications.

  2006cited by this paper
• Pharmacokinetics of Mycophenolic Acid and Metabolites in Diabetic Kidney Transplant Recipients

  2006cited by this paper
• Plasma protein binding of catecholamines, prazosin and propranolol in diabetes mellitus

  2006cited by this paper
• Physical activity and diabetes prevention.

  2005cited by this paper
• Epidemiological evidence for the role of physical activity in reducing risk of type 2 diabetes and cardiovascular disease.

  2005cited by this paper
• Lymphatic system changes in diabetes mellitus: role of insulin and hyperglycemia

  2005cited by this paper
• Inhibition of tumor necrosis factor-α-induced intercellular adhesion molecule-1 expression in diabetic rats: role of insulin

  2005cited by this paper
• Insulin-induced hypoglycemia accelerates gastric emptying of solids and liquids in long-standing type 1 diabetes.

  2005cited by this paper
• Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes.

  2005cited by this paper
• Drug-protein binding kinetics in patients with Type I diabetes

  2005cited by this paper
• Expression and activity of CYP2E1 in circulating lymphocytes are not altered in diabetic individuals.

  2005cited by this paper
• Relation of symptoms to impaired stomach, small bowel, and colon motility in long-standing diabetes

  2005cited by this paper
• Global prevalence of diabetes: estimates for the year 2000 and projections for 2030.

  2004cited by this paper
• Colonic transit time in long-term dialysis patients.

  2004cited by this paper
• Regulation of inosine monophosphate dehydrogenase type I and type II isoforms in human lymphocytes.

  2004cited by this paper
• The Evolving Diabetes Burden in the United States

  2004cited by this paper
• Down-regulation of mast cell activation and airway reactivity in diabetic rats: role of insulin

  2004cited by this paper
• Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs.

  2004cited by this paper
• Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial.

  2004cited by this paper
• Differential effect of Type I and Type II diabetes on antipyrine disposition in man

  2004cited by this paper
• Pharmacokinetics of caffeine in patients with decompensated type I and type II diabetes mellitus

  2004cited by this paper
• Gastroparesis following kidney/pancreas transplant

  2004cited by this paper
• Leukocyte ABCA1 gene expression is associated with fasting glucose concentration in normoglycemic men.

  2004cited by this paper
• Mycophenolic Acid in Diabetic Renal Transplant Recipients: Pharmacokinetics and Application of a Limited Sampling Strategy

  2004cited by this paper
• Relationships between oesophageal transit and solid and liquid gastric emptying in diabetes mellitus

  2004cited by this paper
• ACE inhibitors and diabetic nephropathy: clinical and experimental findings

  2004cited by this paper
• Type 1 diabetic mice are protected from acetaminophen hepatotoxicity.

  2003cited by this paper
• Type 2 diabetic individuals have impaired leg blood flow responses to exercise: role of endothelium-dependent vasodilation.

  2003cited by this paper
• Cytochrome P4502E1 (CYP2E1) expression in peripheral blood lymphocytes: evaluation in hepatitis C and diabetes

  2003cited by this paper
• Impairment of Hepatic Microcirculation in Fatty Liver

  2003cited by this paper
• Posttransplant diabetes mellitus.

  2003cited by this paper
• Diabetes mellitus increases the in vivo activity of cytochrome P450 2E1 in humans.

  2003cited by this paper
• Probucol restores the defective leukocyte-endothelial interaction in experimental diabetes.

  2003cited by this paper
• Regulation of skeletal muscle morphology in type 2 diabetic subjects by troglitazone and metformin: relationship to glucose disposal.

  2003cited by this paper
• Diabetes Mellitus after Kidney Transplantation in the United States

  2003cited by this paper
• Economic costs of diabetes in the US in 2002.

  2003cited by this paper
• Equivalent Pharmacokinetics of Mycophenolate Mofetil in African‐American and Caucasian Male and Female Stable Renal Allograft Recipients

  2003cited by this paper
• Oral Erythromycin and Symptomatic Relief of Gastroparesis: A Systematic Review

  2003cited by this paper
• The antioxidant status during maturation of reticulocytes to erythrocytes in type 2 diabetics.

  2003cited by this paper
• Colonic transit time in diabetic patients--comparison with healthy subjects and the effect of autonomic neuropathy.

  2003cited by this paper
• Oral L-arginine and vitamins E and C improve endothelial function in women with type 2 diabetes

  2003cited by this paper
• Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes.

  2002cited by this paper
• An advanced approach for the assessment of gastric motor function in long-term Type 1 diabetes mellitus with and without autonomic neuropathy

  2002cited by this paper
• Gastric myoelectrical activity and gastric emptying in diabetic patients with dyspeptic symptoms.

  2002cited by this paper
• Session 2: Type 2 Diabetes and MODY

  2002cited by this paper
• Delayed gastric emptying and gastric autoimmunity in type 1 diabetes.

  2002cited by this paper
• Gastric emptying in diabetes: clinical significance and treatment

  2002cited by this paper
• Susceptibility of glutatione and glutathione-related antioxidant activity to hydrogen peroxide in patients with type 2 diabetes: effect of glycemic control.

  2002cited by this paper
• Diabetes and elimination of antipyrine in man: an analysis of 298 patients classified by type of diabetes, age, sex, duration of disease and liver involvement.

  2002cited by this paper
• Dynamic and kinetic disposition of nisoldipine enantiomers in hypertensive patients presenting with type-2 diabetes mellitus

  2002cited by this paper
• Elevated plasma endothelin-1 levels in diabetes mellitus.

  2002cited by this paper
• Impaired postprandial adipose tissue blood flow response is related to aspects of insulin sensitivity.

  2002cited by this paper
• Relationships of upper gastrointestinal motor and sensory function with glycemic control.

  2001cited by this paper
• Predictors of delayed gastric emptying in diabetes.

  2001cited by this paper
• Diabetes mellitus and the stomach

  2001cited by this paper
• Lymphocyte cytochrome P450-CYP2E1 expression in human IDDM subjects.

  2001cited by this paper
• Hospitalizations for fungal infections after renal transplantation in the United States

  2001cited by this paper
• Hepatic cytochrome P450 regulation in disease states.

  2001cited by this paper
• Diabetes and the risk of infection-related mortality in the U.S.

  2001cited by this paper
• Behavioral science research in diabetes: lifestyle changes related to obesity, eating behavior, and physical activity.

  2001cited by this paper

• Clinical outcomes of adverse drug reaction-related hospital admissions in older adults with diabetes

  2026cites this paper
• Preclinical Modeling and Simulation to Explore the Tissue/Plasma Exposure and Pharmacodynamic Effect of Vildagliptin in Diabetes Treatment

  2026cites this paper
• Drug-disease interactions in inflammation: mechanisms, clinical Impact, and future directions.

  2026cites this paper
• Assessing the Safety of Herbal Medicine Use among Type 2 Diabetes Mellitus Patients: A Systematic Review and Meta-analysis.

  2026cites this paper
• Enhanced Sensitivity to Tramadol in Diabetic Neuropathic Pain Compared to Nerve Compression Neuropathies: A Population PK/PD Model Analysis

  2025cites this paper
• Treatment modifiers and predictors of risperidone response in dementia: An individual participant data meta‐analysis of six randomized controlled trials

  2025cites this paper
• An in-depth review of PPARγ modulators as anti-diabetes therapeutics

  2025cites this paper
• Do Diabetes and Genetic Polymorphisms in the COMT and OPRM1 Genes Modulate the Postoperative Opioid Demand and Pain Perception in Osteoarthritis Patients After Total Knee and Hip Arthroplasty?

  2025cites this paper
• Drug exposure and treatment outcomes in patients with multidrug resistant tuberculosis and diabetes mellitus: A multicenter prospective cohort study from China.

  2024cites this paper
• Development of a Physiologically Based Pharmacokinetic Population Model for Diabetic Patients and its Application to Understand Disease-drug–drug Interactions

  2024cites this paper
• Therapeutic potential of orally applied KB-R7943 in streptozotocin-induced neuropathy in rats

  2024cites this paper
• The effect of renal function on the pharmacokinetics and pharmacodynamics of enavogliflozin, a potent and selective sodium‐glucose cotransporter‐2 inhibitor, in type 2 diabetes

  2024cites this paper
• The Validation and Determination of Empagliflozin Concentration in the Presence of Grapefruit Juice Using HPLC for Pharmacokinetic Applications

  2024cites this paper
• Influence of metabolic state and body composition on the action of pharmacological treatment of migraine

  2024influential citation
• Gestational Diabetes Mellitus Does Not Change the Pharmacokinetics and Transplacental Distribution of Fluoxetine and Norfluoxetine Enantiomers

  2024influential citation
• Development of a Population Pharmacokinetic Gabapentin Model Leveraging Therapeutic Drug Monitoring Concentrations

  2024influential citation
• The impact of diabetes mellitus on tuberculosis recurrence in Eastern China: a retrospective cohort study

  2024cites this paper
• Pharmacokinetics-pharmacodynamics of first-line antitubercular drugs: a comparative study in tuberculosis patients with and without concomitant diabetes mellitus

  2024influential citation
• Optimizing the dosing regimen of roxadustat in kidney transplant recipients with early post-transplant anemia.

  2024cites this paper
• The Effect of Diabetes Mellitus on the Pharmacokinetics of Tuberculosis Drugs

  2023cites this paper
• Evaluation of important human CYP450 isoforms and P‐glycoprotein phenotype changes and genotype in type 2 diabetic patients, before and after intensifying treatment regimen using Geneva cocktail

  2023cites this paper
• Impact of glycaemic control and CYP3A5 polymorphisms on tacrolimus trough concentrations after adult kidney transplantation

  2023cites this paper
• Impact of protein deficient diet on the pharmacokinetics of glibenclamide in a model of malnutrition in rats

  2023cites this paper
• Individualized dosing algorithms for tacrolimus in kidney transplant recipients: current status and unmet needs

  2023cites this paper
• Pharmacokinetic relevance of glomerular hyperfiltration for drug dosing

  2023cites this paper
• Pharmacokinetic Herb-Drug Interactions of Glipizide with Andrographis paniculata (Burm. f.) and Andrographolide in Normal and Diabetic Rats by Validated HPLC Method

  2022cites this paper
• Drug Disposition Protein Quantification in Matched Human Jejunum and Liver From Donors With Obesity

  2022cites this paper
• Acrylamide and glycidamide in plasma of diabetic and non-diabetic rats, a comparative toxicokinetic study

  2022influential citation
• Comparison of pharmacokinetic parameters of ranolazine between diabetic and non-diabetic rats

  2022cites this paper
• An Updated Systematic Review of Vaccinium myrtillus Leaves: Phytochemistry and Pharmacology

  2022cites this paper
• Perspectives on Using Fast-Dissolving Paracetamol for Mild-to-Moderate Pain Management in Elderly or Diabetic Patients with Delayed Gastric Emptying Rates: An Exploratory Study

  2022cites this paper
• Pharmacokinetic assessment of cefpodoxime proxetil in diabetic rats

  2022cites this paper
• Prameha purvaroopa as diabetes risk predictor - trends from a retrospective cohort study of newly diagnosed type 2 diabetes patients.

  2022cites this paper
• The Role of CYP3A in Health and Disease

  2022cites this paper
• Impact of type 2 diabetes on in vivo activities and protein expressions of cytochrome P450 in patients with obesity

  2022cites this paper
• Pharmacokinetics and safety/tolerability of isoniazid, rifampicin and pyrazinamide in children and adolescents treated for tuberculous meningitis

  2021cites this paper
• Gender, age, disease severity, body mass index and diabetes may not affect response to subcutaneous tanezumab in patients with osteoarthritis after 16 weeks of treatment. A subgroup analysis of placebo‐controlled trials

  2021cites this paper
• Effect of Nigella sativa oil on pharmacokinetics and pharmacodynamics of gliclazide in rats

  2021cites this paper
• Interim Effectiveness and Safety Comparison of Bedaquiline-Containing Regimens for Treatment of Diabetic Versus Non-Diabetic MDR/XDR-TB Patients in China: A Multicenter Retrospective Cohort Study

  2021cites this paper
• Diabetes mellitus aggravates ranolazine-induced ECG changes in rats

  2021cites this paper
• Streptozotocin-Induced Hyperglycemia Affects the Pharmacokinetics of Koumine and its Anti-Allodynic Action in a Rat Model of Diabetic Neuropathic Pain

  2021cites this paper
• Evaluation of Cinnamon (Cinnamomum Verum) Effects on Liver CYP450 2D1 Activity and Hepatic Clearance in Diabetic Rats

  2021cites this paper
• Potential Alteration of Statin-Related Pharmacological Features in Diabetes Mellitus

  2021cites this paper
• Challenges in Antifungal Therapy in Diabetes Mellitus

  2020cites this paper
• Benefits of Therapeutic Drug Monitoring of First Line Antituberculosis Drugs

  2020cites this paper
• Drug Elimination Alteration in Acute Lymphoblastic Leukemia Mediated by Renal Transporters and Glomerular Filtration

  2020cites this paper
• Population pharmacokinetic analysis of bisoprolol in type 2 diabetic patients with hypertension

  2020cites this paper
• Utility of Quantitative Proteomics for Enhancing the Predictive Ability of Physiologically Based Pharmacokinetic Models Across Disease States

  2020cites this paper
• Population pharmacokinetic analysis of bisoprolol in type 2 diabetic patients with hypertension

  2020cites this paper
• Lower Cumulative Antiretroviral Exposure in People Living With HIV and Diabetes Mellitus.

  2020cites this paper
• Population pharmacokinetics of gabapentin in patients with neuropathic pain: Lack of effect of diabetes or glycaemic control

  2020cites this paper
• Prevalence of Adverse Drug Events in Severely Obese Adults and Associated Factors: Clinical Trial Baseline Results

  2020cites this paper
• The Mechanism of Jinqi Jiangtang Tablet in Treatment of Type 2 Diabetes Mellitus Based on Network Pharmacology

  2020cites this paper
• Toxicokinetics of methylmercury in diabetic KK‐Ay mice and C57BL/6 mice

  2020cites this paper
• Histopathological and biochemical alterations in non-diabetic and diabetic rats following acrylamide treatment

  2019cites this paper
• Reply to Acetaminophen Use and Stroke Risk

  2019cites this paper
• Availability of Evidence‐Based Community Falls Prevention Programs: Considerations

  2019cites this paper
• Effect of diabetes mellitus on TB drug concentrations in Tanzanian patients

  2019cites this paper
• Prediction of Atorvastatin Pharmacokinetics in High-Fat Diet and Low-Dose Streptozotocin-Induced Diabetic Rats Using a Semiphysiologically Based Pharmacokinetic Model Involving Both Enzymes and Transporters

  2019cites this paper
• Influence of Obesity and Type 2 Diabetes Mellitus on the Pharmacokinetics of Tramadol After Single Oral Dose Administration

  2019influential citation
• Pathophysiology and management of diabetic gastroenteropathy

  2019cites this paper
• The effect of diabetes mellitus on pharmacokinetics, pharmacodynamics and adverse drug reactions of anticancer drugs

  2019cites this paper
• Frequency of CYP2C9 (*2, *3 and IVS8-109A>T) allelic variants, and their clinical implications, among Mexican patients with diabetes mellitus type 2 undergoing treatment with glibenclamide and metformin

  2019cites this paper
• Understanding the relevance of herb–drug interaction studies with special focus on interplays: a prerequisite for integrative medicine

  2019cites this paper
• Welcome to Podiatry Management’s CME Instructional program. Podiatry Management Magazine is approved by the Council on Podiatric Medical Education as a provider of continuing education in podiatric medicine. Podiatry Management

  2019cites this paper
• The regulation of drug-metabolizing enzymes and membrane transporters by inflammation: Evidences in inflammatory diseases and age-related disorders

  2018cites this paper
• The role of organic cation transporter 2 inhibitor cimetidine, experimental diabetes mellitus and metformin on gabapentin pharmacokinetics in rats

  2018cites this paper
• Theoretical overview of clinical and pharmacological aspects of the use of etelcalcetide in diabetic patients undergoing hemodialysis

  2018cites this paper
• Changes in CYP2D enzyme activity following induction of type 2 diabetes, and administration of cinnamon and metformin: an experimental animal study

  2018cites this paper
• Randomized open‐label crossover assessment of Prograf vs Advagraf on immunosuppressant pharmacokinetics and pharmacodynamics in simultaneous pancreas‐kidney patients

  2018cites this paper
• Fixed-dose combination associated with faster time to smear conversion compared to separate tablets of anti-tuberculosis drugs in patients with poorly controlled diabetes and pulmonary tuberculosis in Qatar

  2018cites this paper
• The Influence of Diabetes Mellitus on Glucuronidation and Sulphation of Paracetamol in Patients with Febrile Neutropenia

  2018cites this paper
• Risk of adverse treatment outcomes among new pulmonary TB patients co-infected with diabetes in Pakistan: A prospective cohort study

  2018cites this paper
• Expression and Activity of CYP2C8 and 2C9 in Diabetes Mellitus and Nonalcoholic Fatty Liver Disease

  2018cites this paper
• Effect of Diabetes on the Pharmacokinetic Profile of Fluoroquinolones

  2018cites this paper
• Regulation of Human CYP2D6

  2018cites this paper
• Theoretical overview of clinical and pharmacological aspects of the use of etelcalcetide in diabetic patients undergoing hemodialysis

  2018cites this paper
• Salicylic acid retention impairs aspirin reactivity in type 2 diabetes

  2017cites this paper
• Clinical and pharmacological hallmarks of rifapentine’s use in diabetes patients with active and latent tuberculosis: do we know enough?

  2017cites this paper
• Clinical Pharmacokinetics and Pharmacodynamics of Antihyperglycemic Medications in Children and Adolescents with Type 2 Diabetes Mellitus

  2017cites this paper
• Pharmacogenomics: sex Differences and Application in Pediatrics

  2017cites this paper
• Population pharmacokinetics of carvedilol enantiomers and their metabolites in healthy subjects and type‐2 diabetes patients

  2017cites this paper
• Clinical Determinants of Target Non-Attainment of Linezolid in Plasma and Interstitial Space Fluid: A Pooled Population Pharmacokinetic Analysis with Focus on Critically Ill Patients

  2017cites this paper
• Effects of Type 2 Diabetes Mellitus in Patients on Treatment With Glibenclamide and Metformin on Carvedilol Enantiomers Metabolism

  2017cites this paper
• Effect of type 2 diabetes mellitus on the pharmacokinetics and transplacental transfer of nifedipine in hypertensive pregnant women

  2017cites this paper
• Comparative Assessment of Tedizolid Pharmacokinetics and Tissue Penetration between Diabetic Patients with Wound Infections and Healthy Volunteers via In Vivo Microdialysis

  2017cites this paper
• Model‐Based Approach to Predict Adherence to Protocol During Antiobesity Trials

  2017cites this paper
• Impact of hyperglycemia on the efficacy of chemotherapy-A systematic review of preclinical studies.

  2017cites this paper
• Variables Influencing the Depth of Conscious Sedation in Plastic Surgery: A Prospective Study

  2017cites this paper
• Pharmacogenomics: sex differences and application in pediatrics1

  2017cites this paper
• Non-alcoholic fatty liver disease (NAFLD) – pathogenesis, classification, and effect on drug metabolizing enzymes and transporters

  2017cites this paper
• Requirements for the formal representation of pathophysiology mechanisms by clinicians

  2016cites this paper
• Influence of diabetes mellitus on pharmacokinetics of drugs

  2016cites this paper
• The role of the pharmacist in the management of kidney transplant recipients

  2016cites this paper
• Convergence of a diabetes mellitus, protein energy malnutrition, and TB epidemic: the neglected elderly population

  2016cites this paper
• Monoclonal Antibody Pharmacokinetics in Type 2 Diabetes Mellitus and Diabetic Nephropathy

  2016cites this paper
• Use of bedaquiline and delamanid in diabetes patients: clinical and pharmacological considerations

  2016cites this paper
• Microsoft Word-3786021-file00

  2015cites this paper
• DMD064881 1702..1710

  2015cites this paper
• Combined contribution of increased intestinal permeability and inhibited deglycosylation of ginsenoside Rb1 in intestinal tract to the enhancement of ginsenoside Rb1 exposure in diabetic rats following oral administration

  2015cites this paper